K. COHEN*, A. TZIKA, H. WOOD, S. BERRI, P. ROBERTS, G. MASON* and E. SHERIDAN
|
|
- Asher Powers
- 5 years ago
- Views:
Transcription
1 Ultrasound Obstet Gynecol 05; 45: Published online in Wiley Online Library (wileyonlinelibrary.com). DOI: 0.00/uog.4767 Diagnosis of fetal submicroscopic chromosomal abnormalities in failed array CGH samples: copy number by sequencing as an alternative to microarrays for invasive fetal testing K. COHEN*, A. TZIKA, H. WOOD, S. BERRI, P. ROBERTS, G. MASON* and E. SHERIDAN *Department of Fetal Medicine, Leeds General Infirmary, Leeds, UK; Leeds Institute of Cancer and Pathology, Leeds, UK; Department of Cytogenetics, St James s University Hospital, Leeds, UK; Illumina UK Ltd, Chesterford Research Park, Little Chesterford, Essex, UK KEYWORDS: array CGH limitations; molecular karyotyping; prenatal CNV-Seq ABSTRACT Objectives Array comparative genomic hybridization (CGH) has become the technology of choice for high-resolution prenatal whole genome analysis. Limitations of microarrays are mainly related to the analog nature of the analysis, and poor-quality DNA can result in failed quality metrics with these platforms. We examined a cohort of abnormal fetuses with failed array CGH results using a next-generation sequencing algorithm, CNV-Seq. We assessed the ability of the platform to handle suboptimal prenatal samples and generate interpretable molecular karyotypes. Methods Nine samples obtained from abnormal fetuses and one from a normal control fetus were sequenced using an Illumina GAIIx. A segmentation algorithm for sequencing data was used to determine regional copy number data on the sequencing datasets. Results Phred quality scores were satisfactory for analysis of all samples. CNV-Seq identified both large- and small-scale abnormalities in the cohort, and normal results were obtained for fetuses for which microarray data were previously uninterpretable. No variants of uncertain significance were detected. Analysis of the digital sequencing datasets offered some advantages over array CGH output. Conclusions Using next-generation sequencing for the detection of genomic copy number variants may be advantageous for poor-quality, invasively-acquired prenatal samples. CNV-Seq could become a potential alternative to array CGH in this setting. Copyright 04 ISUOG. Published by John Wiley & Sons Ltd. INTRODUCTION Array comparative genomic hybridization (CGH) has become the gold standard investigation for the postnatal diagnosis of genomic copy number variants (CNVs). Challenges specific to prenatal diagnosis have resulted in cautious adoption of this technology, and the implementation of arrays into fetal diagnostics in the UK National Health Service is still not fully established. However, it is clear that microarray analysis offers a significant improvement in the diagnostic yield over standard antenatal karyotyping, especially in cohorts of structurally-abnormal fetuses or stillbirths,. Although the advantages of array CGH are clear, the relatively short lifespan of the technology to date means that potential disadvantages are still emerging. While the detection of variants of uncertain significance (VOUS) is the most challenging drawback of the technology so far encountered, other difficulties have been acknowledged. Technical challenges when using prenatal tissue have been reported with array CGH platforms, primarily issues with low volumes of, and poor-quality, DNA 4. Although culturing of tissue may overcome the problem of DNA quantity, the impact on turnaround time is undesirable in the prenatal setting. Poor-quality, contaminated or fragmented DNA can perform poorly on array CGH platforms, owing mainly to suboptimal hybridization or an increased signal generated by contaminants 5. The analog nature of array technology could be considered an increasing disadvantage in the era of next-generation sequencing. Initially described in 009 6, CNV mapping by sequencing is a digital approach, relying on numerical differences between aligned reads from different individuals. Correspondence to: Dr K. Cohen, Department of Fetal Medicine, Clarendon Wing, Leeds General Infirmary, Leeds, LS EX, UK ( k.cohen@nhs.net) Accepted: 0 December 04 Copyright 04 ISUOG. Published by John Wiley & Sons Ltd. ORIGINAL PAPER
2 Copy number by sequencing for invasive fetal testing 95 To compare test and control samples, segmentation algorithms create consecutive read windows, positioned equally in both genomes 7. Read counts, or the number of sequenced fragments per segment, can then be compared. A reduction in read count in a particular test window suggests a deletion in that region, and an increase in reads suggests a duplication. This segmental approach has allowed the resolution of 5 kb CNVs using ultra-low read depths with costs comparable to those of array CGH 8,9. With sequencing, successful detection of CNVs from archived picoquantities of DNA has been reported 8, and the ability to add oligonucleotide barcodes to individual samples means that multiple genomes can be processed simultaneously, reducing costs significantly. Using CNV-Seq, we analyzed a cohort of prenatal samples obtained from abnormal fetuses that had previously failed array CGH quality-control parameters. METHODS Nine fetal samples were selected for CNV-Seq (Table ), all of which had been analyzed previously using the BlueGnome Cytochip Focus (Illumina, San Diego, CA, USA) microarray (version ). This bacterial artificial chromosome (BAC)-based array is optimized specially for use with challenging tissue samples by applying increased probe replication and data smoothing algorithms. For the samples analyzed by CNV-Seq, array CGH experiments had failed owing to inadequate probe-inclusion ratios and increased signal-to-noise ratios, as measured by the standard deviation of each autosome on the array. Two samples used were known to be abnormal; a sample with aneuploidy was included to assess the effect of multiplexing on the detection of large-scale abnormalities and another sample appeared to contain a submicroscopic rearrangement on array CGH, but the quality scores were too poor to report. Genomic DNA was extracted from uncultured chorionic villi and amniotic fluid using the Gentra Puregene Micro-DNA kit (Qiagen, Venlo, Limburg, The Netherlands). DNA concentration and purity were determined using the Quant-iT PicoGreen dsdna BR (Life Technologies, Inchinnan Business Park, Paisley, UK) assay and the Agilent Bioanalyser Genechip (Agilent Technologies, Santa Clara, CA, USA). For each sample, μg of genomic DNA was used to prepare the DNA libraries for sequencing on an Illumina GAIIx (Illumina) sequencing platform. Pooled DNA, obtained from 50 normal individuals, was used as a control. Fetal DNA was sheared to approximately base pairs (bp) using adaptive focused acoustics. Fragments were purified using MinElute (Qiagen) columns, and overhanging ends repaired using the End-It DNA End-Repair kit (Epicentre, Cambridge, UK). Using previously described methods, 6-nucleotide barcodes were used to index the samples 8. Fragments were selected by size to 00 bp using gel-cut electrophoresis. Following polymerase chain reaction amplification, the libraries were purified on a QiaQuick (Qiagen) column and quality-checked using an Agilent Bioanalyser DNA 000 LabChip (Agilent), with Table Phenotype and array comparative genomic hybridization (CGH) quality-control (QC) metrics of nine DNA samples obtained from abnormal fetuses Sample Abnormality Array CGH result SD autosome* Probe inclusion (%) Increased NT Failed QC Increased NT 47,XY Isolated cerebral ventriculomegaly at weeks Failed QC but del 7p; dup 0q Increased NT Failed QC Exomphalos at weeks Failed QC Bilateral talipes and cardiac defect Failed QC Increased NT Failed QC Exomphalos Failed QC Increased NT Failed QC *SD < 0.4 is acceptable. > 95% is acceptable. del, deletion; dup, duplication; NT, nuchal translucency. Table CNV-Seq data of nine DNA samples obtained from abnormal fetuses Sample Total read count Mean window size (kb)* Mean resolution (kb) CNV-Seq result Trisomy Normal Normal Normal Normal Normal Normal del 7p; dup 0q Normal *Genomic length containing 00 aligned reads. Span of two read windows. del, deletion; dup, duplication.
3 96 Cohen et al. (a) X Y Chromosome (b) Log ratio Ch/Ch X Y Chromosomal position Figure Sequencing karyogram from CNV-Seq (a) and corresponding array comparative genomic hybridization result (b) across the whole genome of a normal fetus. For CNV-Seq, each data point represents a single read window, each containing 00 reads. The x-axis displays the chromosomal location of the windows. The y-axis shows the haploid equivalents present in the test sample, when compared with the normal control. As expected in a normal fetus, the haploid equivalent is for the entire genome. quantification performed by a Quant-iT Picogreen double-stranded DNA assay (Life Technologies). Equal amounts of each tagged library were then pooled for cluster generation and sequencing using the standard Illumina single-read 76-cycle operating protocol ( instruments/genome_analyzer_iix.html). Data analysis Image analysis, base calling quality scores and alignment were performed using the Illumina CASAVA pipeline (UCSC build hg9). Initially, samples were separated according to their tags. The control genome was then segmented into non-overlapping windows, each containing 00 reads, and the same windows were then applied to each fetal sample. The number of reads falling into each corresponding window was then counted. Subsequent analysis performed in R software (Revolution Analytics, Mountain View, CA, USA ( normalized the read counts across the genome and calculated a log ratio of normalized sample (control read count for each window). A mean log ratio was then generated for consecutive windows and used to produce graphical representations of copy number variation for each patient. RESULTS The fetal samples and one normal control were sequenced in a 0-plex experiment producing a total of reads. The depth of coverage obtained was 8,
4 Copy number by sequencing for invasive fetal testing 97 (a) X Y Chromosome (b) Log ratio Ch/Ch X Y Chromosomal position Figure (a) Sequencing karyogram of a sample from a fetus with trisomy. (b) Noisy array comparative genomic hybridization karyogram from same fetus. calculated by the number of reads/total number of genome base pairs ( 0 9 ) ratio. In Table, the overall read count, mean genomic resolution and variant breakpoints are shown for each sample. A window size of 00 reads was used to analyze the data (Figures and ). Base calling quality scores were satisfactory, with a Phred quality score of 0, indicating base call accuracy of 99.9%. Figure shows the submicroscopic rearrangement detected by both platforms, and the breakpoint positions of these rearrangements are seen in Table. The corresponding array CGH chromosomal ideogram for the deletion on chromosome 7 is also shown (Figure b). In this sample, a.89-mb deletion of nine consecutive probes was detected on chromosome 7p by the array CGH platform. The duplication identified on chromosome 0 was a large rearrangement, with start and end clone positions suggestive of up to 6.9 MB in size. Definitive sizes of the variants were not ascertainable, as the wide tiling of probes in these regions meant that the exact breakpoints lay within a genomic range, somewhere between the span of the start and end clones. In the CNV-Seq karyograms, the terminal deletion of 7p is indicated by the presence of haploid equivalents. On chromosome 0, the duplicated segments are clearly evident as a region of haploid equivalents (Figure ). A small number of unexpected calls were made by the software and required further analysis (Table 4). Interrogation of the genomic positions of these data points revealed that all of these regions were contained within the centromeres of the chromosomes (Figure 4), and were excluded from further study owing to the known problems with read alignment within these areas.
5 98 Cohen et al. (a) (c) (b) Log Ratio Ch Chromosome Log ratio Ch/Ch X Figure Submicroscopic chromosomal abnormality detected by CNV-Seq and array comparative genomic hybridization (acgh) of a sample obtained from a structurally abnormal fetus. (a) CNV-Seq karyogram reveals a deletion of 7p. (b) acgh ideogram for chromosome 7 shows a limited number of probes included in the analysis but the terminal deletion is evident. (c) The duplication of 0p was detected by the CNV-Seq platform. DISCUSSION The findings from our study indicate that poor-quality DNA did not appear to have a deleterious effect on the next-generation sequencing data output. All samples had been analyzed previously by array CGH, but interpretation was not possible owing to the failure of quality-control metrics. Subsequent sequencing of the same degraded DNA by CNV-Seq produced sequencing datasets with acceptable quality scores. However, the main difference between the outputs was the absence of the multiple single-clone calls that had characterized the arrays of these samples. This noise was not evident when using CNV-Seq. As the DNA samples were randomly
6 Copy number by sequencing for invasive fetal testing 99 Table Breakpoints of the submicroscopic chromosomal abnormalities detected in a DNA sample obtained from a structurally abnormal fetus Window position (genomic loci) Submicroscopic abnormality Left flanking Start End Right flanking Minimum size (kb) Maximum size (kb) del 7p dup 0q del, deletion; dup, duplication. Table 4 Calls made by the CNV-Seq algorithm that required further analysis after sequencing of nine DNA samples obtained from abnormal fetuses Sample Chromosome Genomic start position Genomic end position Log ratio Figure 4 A centromeric call in CNV-Seq. Alignment is poor in highly repetitive areas of the genome and a disproportionate number of reads may align in these regions. cut prior to sequencing, the fragmenting effects of DNA degradation may have been attenuated. The digital nature of the analysis, not relying on the assessment of fluorescence intensities, may have resulted in a less spurious signal from experimental contaminants. It is possible that technical errors with in-house DNA extraction or array processing impacted upon the DNA quality. The platform used in this study was a BAC-based array, technology that has been superseded mostly by oligoarrays. Certainly, the problem of single-clone calls has largely disappeared since this transition 0. Recent meta-analysis data would suggest that most prenatal array experiments do not fail. However, in many cohorts, problems with using poor-quality DNA have been overcome by the use of culturing, with up to one in five results relying on cultured samples. Whole genome amplification has been utilized but raises the possible difficulties of amplification bias, and, overall, the prevalence of failed direct DNA in prenatal arrays is not clear. To our knowledge, no failed array CGH samples have been analyzed previously using this particular algorithm, although sequencing of archived tumor and constitutional samples has shown similar advantages 8. Similar work has been reported for postnatal samples, using the same platform, with the detection of genomic variants comparable with that of an oligoarray platform 9. Challenging samples, such as those obtained from pregnancy loss or stillbirth, may be especially suited to analysis by CNV-Seq. For this method of analysis, the resolution was defined as being equal to the length of two genomic read windows. The range of resolution obtained across the samples was between 94.8 and 89. kb. Abnormalities less than the span of two consecutive windows were assumed to remain undetected with this platform, similar to gaps between probes on an array. Low read depths were produced by multiplexing, an approach widely adopted in constitutional genomics. As each lane of the sequencer produces a finite number of reads, multiplexing reduces proportionally the read depth per sample. Processing of up to 96 samples per lane is possible with newer sequencing platforms, allowing a choice of increased depth or higher throughput. In CNV-Seq, high depth of coverage appears to increase sensitivity and detection rates. Ultra-low coverage, as in this project, has the advantage of reduced costs but is adequate only for detecting relatively large-scale variants when compared with deep sequencing. In this small project, the control genome was segmented into non-overlapping windows containing approximately 00 test reads. These windows were then applied to the test genomes. Different sized windows may be selected and the data analysis repeated in silico without the requirement for further experiments, and the ability to manipulate the dataset digitally is another potential advantage over arrays. Figure 5 shows the same chromosomal abnormality as in Figure, analyzed by both a 400 read window and a 50 read window. It is
7 400 Cohen et al. K5F chromosome 7 K5 chromosome 7 (a) (b) Figure 5 Different window sizes used for analyzing chromosome 7. Altering the window size on the data points available for analysis has an effect on results: (a) 400 read window; (b) 50 read window. evident that when the window size is very small, the increased number of data points in the karyograms could be a disadvantage, analogous to increased signal/noise ratios in array CGH experiments. Large window sizes resulted in very few datapoints available for analysis, and a reduced resolution. Digital approaches such as CNV-Seq offer the possibility of flexibly manipulating the resolution using alterations in read depth and window size, rather than changing platforms. For the submicroscopic rearrangement, CNV-Seq allowed the improved assessment of genomic breakpoints. The windows were smaller than the BAC probes, and the genomic positions of the start and end windows were available. Although the read count was not sufficient to determine exact breakpoints, this compared favorably with the array CGH platform. Rare variants in any reference genome may manifest as dosage change in a test sample 9. A potential advantage of next-generation sequencing is that in-silico controls can be utilized for each run, reducing costs. A control sample can be prepared by merging sequencing data from a large number of normal individuals, offering an advantage over array CGH, in which each experiment requires a fresh control to be processed. The software called a number of possible variants that mapped to genomic regions of high repeat sequences. Alignment in these regions is known to be reduced, particularly at the centromeres and telomeres 4. Calls were excluded based on either their small size or their centromeric or telomeric position, and no VOUS that required follow-up were detected. The small number of samples analyzed precludes any conclusions regarding detection rates and VOUS. With a resolution similar to that of oligoarray platforms, it is almost certain that using CNV-Seq on larger cohorts would reveal VOUS. Larger studies are needed before the apparent improvement in false-positive calls can be verified. Laboratory time for a sequencing reaction was similar to that required by array CGH, with data output ready for analysis within days. In spite of the large digital datasets, the time taken to produce a molecular karyogram was 4 h. Microarray platforms target coverage to regions of interest, using increased probe density. In CNV-Seq, genome coverage is proportional to read depth and cannot be targeted to specific regions. Array platforms that interrogate single nucleotide polymorphisms (SNPs) alongside oligoarray data have been shown to increase the detection of pathogenic variation 5 ; CNV-Seq is a low-read depth platform and will not detect SNPs. SNP platforms also utilize digital controls, minimizing the effects of control variation, and are able to detect loss of heterozygosity indicating potential recessive conditions. CONCLUSIONS Genomic diagnosis of fetal abnormalities facilitates both reproductive choice and an accurate assessment of the risk of recurrence for families. Enormous transitions are underway in genomic testing, and the availability of increasingly high-resolution array platforms has been coupled with dramatic falls in sequencing costs. There is now the very real possibility that convergence of technology will result in a single platform for the detection of genomic variation, from SNP to aneuploidy. At present, CNV-Seq and other sequencing-based copy number detection platforms may offer advantages when tissue samples are of poor quality or when array CGH fails. Further assessment is needed to determine the optimal operating parameters for prenatal diagnosis.
8 Copy number by sequencing for invasive fetal testing 40 REFERENCES. Reddy UM, Page GP, Saade GR, Silver RM, Thorsten VR, Parker CB, Pinar H, Willinger M, Stoll BJ, Heim-Hall J, Varner MW, Goldenberg RL, Bukowski R, Wapner RJ, Drews-Botsch CD, O Brien BM, Dudley DJ, Levy B; NICHD Stillbirth Collaborative Research Network. Karyotype versus microarray testing for genetic abnormalities after stillbirth. NEnglJMed0; 67: Wapner RJ, Martin CL, Levy B, Ballif BC, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, Klugman S, Scholl T, Simpson JL, McCall K, Aggarwal VS, Bunke B, Nahum O, Patel A, Lamb AN, Thom EA, Beaudet AL, Ledbetter DH, Shaffer LG, Jackson L. Chromosomal microarray versus karyotyping for prenatal diagnosis. NEnglJMed0; 67: Hillman S, McMullan D, Hall G, Togneri F, James N, Meller C, Williams D, Wapner R, Maher E, Kilby M. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis. Ultrasound Obstet Gynecol 0; 4: Bi W, Breman AM, Venable SF, Eng PA, Sahoo T, Lu XY, Patel A, Beaudet AL, Cheung SW, White LD. Rapid prenatal diagnosis using uncultured amniocytes and oligonucleotide array CGH. Prenat Diagn 008; 8: Hehir-Kwa JY, Egmont-Petersen M, Janssen IM, Smeets D, van Kessel AG, Veltman JA. Genome-wide copy number profiling on high-density bacterial artificial chromosomes, single-nucleotide polymorphisms, and oligonucleotide microarrays: a platform comparison based on statistical power analysis. DNA Res 007; 4:. 6. Xie C, Tammi MT. CNV-seq, a new method to detect copy number variation using high-throughput sequencing. BMC Bioinformatics 009; 0: Koboldt DC, Larson DE, Chen K, Ding L, Wilson RK. Massively parallel sequencing approaches for characterization of structural variation. Methods Mol Biol 0; 88: Wood HM, Belvedere O, Conway C, Daly C, Chalkley R, Bickerdike M, McKinley C, Egan P, Ross L, Hayward B, Morgan J, Davidson L, MacLennan K, Ong TK, Papagiannopoulos K, Cook I, Adams DJ, Taylor GR, Rabbitts P. Using next-generation sequencing for high resolution multiplex analysis of copy number variation from nanogram quantities of DNA from formalin-fixed paraffin-embedded specimens. Nucleic Acids Res 00: 8: e5. 9. Hayes JL, Tzika A, Thygesen H, Berri S, Wood HM, Hewitt S, Pendlebury M, Coates A, Willoughby L, Watson CM, Rabbitts P, Roberts P, Taylor GR. Diagnosis of copy number variation by Illumina next generation sequencing is comparable in performance to oligonucleotide array comparative genomic hybridisation. Genomics 0; 0: Pinto D, Darvishi K, Shi X, Rajan D, Rigler D, Fitzgerald T, Lionel AC, Thiruvahindrapuram B, Macdonald JR, Mills R, Prasad A, Noonan K, Gribble S, Prigmore E, Donahoe PK, Smith RS, Park JH, Hurles ME, Carter NP, Lee C, Scherer SW, Feuk L. Comprehensive assessment of array-based platforms and calling algorithms for detection of copy number variants. Nat Biotechnol 0; 9: Meyer M, Stenzel U, Myles S, Prüfer K, Hofriter M. Targeted high-throughput sequencing of tagged nucleic acid samples. Nucleic Acids Res 007; 5: e97.. Metzker ML. Sequencing technologies the next generation. Nat Rev Genet 00; : 46.. Nord AS, Lee M, King MC, Walsh T. Accurate and exact CNV identification from targeted high-throughput sequence data. BMC Genomics 0; : Zhao M, Wang Q, Wang Q, Jia P, Zhao Z. Computational tools for copy number variation (CNV) detection using next-generation sequencing data: features and perspectives. BMC Informatics 0; 4 (Supp ): S. 5. Ganesamoorthy D, Bruno DL, McGillivray G, Norris F, White SM, Adroub S, Amor DJ, Yeung A, Oertel R, Pertile MD, Ngo C, Arvaj AR, Walker S, Charan P, Palma-Dias R, Woodrow N, Slater HR. Meeting the challenge of interpreting high-resolution single nucleotide polymorphism array data in prenatal diagnosis: does increased diagnostic power outweigh the dilemma of rare variants? BJOG 0;0:
Cytogenetics 101: Clinical Research and Molecular Genetic Technologies
Cytogenetics 101: Clinical Research and Molecular Genetic Technologies Topics for Today s Presentation 1 Classical vs Molecular Cytogenetics 2 What acgh? 3 What is FISH? 4 What is NGS? 5 How can these
More informationPrenatal Diagnosis: Are There Microarrays in Your Future?
Financial Disclosure UCSF Antepartum Intrapartum Management Course June 8 I have no financial relationship with any aspect of private industry Prenatal Diagnosis: Are There Microarrays in Your Future?
More informationNew and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads
New and Developing Technologies for Genetic Diagnostics National Genetics Reference Laboratory (Wessex) Salisbury, UK - July 2010 BACs on Beads Susan Gross, MD Division of Reproductive Genetics Professor
More informationChromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases
Chromosome microarray analysis in routine prenatal diagnosis practice: a prospective study on 3000 consecutive clinical cases Fiorentino F, Napoletano S, Caiazzo F, Sessa M, Bono S, Spizzichino L, Gordon
More informationAssociation for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology
Association for Molecular Pathology Promoting Clinical Practice, Basic Research, and Education in Molecular Pathology 9650 Rockville Pike, Bethesda, Maryland 20814 Tel: 301-634-7939 Fax: 301-634-7990 Email:
More informationCNV Detection and Interpretation in Genomic Data
CNV Detection and Interpretation in Genomic Data Benjamin W. Darbro, M.D., Ph.D. Assistant Professor of Pediatrics Director of the Shivanand R. Patil Cytogenetics and Molecular Laboratory Overview What
More informationSupplementary note: Comparison of deletion variants identified in this study and four earlier studies
Supplementary note: Comparison of deletion variants identified in this study and four earlier studies Here we compare the results of this study to potentially overlapping results from four earlier studies
More informationCHROMOSOMAL MICROARRAY (CGH+SNP)
Chromosome imbalances are a significant cause of developmental delay, mental retardation, autism spectrum disorders, dysmorphic features and/or birth defects. The imbalance of genetic material may be due
More informationImplementation of the DDD/ClinGen OGT (CytoSure v3) Microarray
Implementation of the DDD/ClinGen OGT (CytoSure v3) Microarray OGT UGM Birmingham 08/09/2016 Dom McMullan Birmingham Women's NHS Trust WM chromosomal microarray (CMA) testing Population of ~6 million (10%)
More informationChallenges of CGH array testing in children with developmental delay. Dr Sally Davies 17 th September 2014
Challenges of CGH array testing in children with developmental delay Dr Sally Davies 17 th September 2014 CGH array What is CGH array? Understanding the test Benefits Results to expect Consent issues Ethical
More informationGenomic structural variation
Genomic structural variation Mario Cáceres The new genomic variation DNA sequence differs across individuals much more than researchers had suspected through structural changes A huge amount of structural
More informationApplications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns
Applications of Chromosomal Microarray Analysis (CMA) in pre- and postnatal Diagnostic: advantages, limitations and concerns جواد کریمزاد حق PhD of Medical Genetics آزمايشگاه پاتوبيولوژي و ژنتيك پارسه
More informationAbstract. Optimization strategy of Copy Number Variant calling using Multiplicom solutions APPLICATION NOTE. Introduction
Optimization strategy of Copy Number Variant calling using Multiplicom solutions Michael Vyverman, PhD; Laura Standaert, PhD and Wouter Bossuyt, PhD Abstract Copy number variations (CNVs) represent a significant
More informationDNA-seq Bioinformatics Analysis: Copy Number Variation
DNA-seq Bioinformatics Analysis: Copy Number Variation Elodie Girard elodie.girard@curie.fr U900 institut Curie, INSERM, Mines ParisTech, PSL Research University Paris, France NGS Applications 5C HiC DNA-seq
More informationDetection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit
APPLICATION NOTE Ion PGM System Detection of aneuploidy in a single cell using the Ion ReproSeq PGS View Kit Key findings The Ion PGM System, in concert with the Ion ReproSeq PGS View Kit and Ion Reporter
More informationHuman Genetic Variation Copy Number Variation
The Evolution of Laboratory Prenatal Diagnosis Lawrence D. Platt, MD Professor of Obstetrics and Gynecology David Geffen School of Medicine at UCLA Center for Fetal Medicine & Women s Ultrasound Los Angeles,
More informationGenerating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University
Role of Chemical lexposure in Generating Spontaneous Copy Number Variants (CNVs) Jennifer Freeman Assistant Professor of Toxicology School of Health Sciences Purdue University CNV Discovery Reference Genetic
More informationCURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE. Dr. Bahar Naghavi
2 CURRENT GENETIC TESTING TOOLS IN NEONATAL MEDICINE Dr. Bahar Naghavi Assistant professor of Basic Science Department, Shahid Beheshti University of Medical Sciences, Tehran,Iran 3 Introduction Over 4000
More informationCorporate Medical Policy
Corporate Medical Policy Invasive Prenatal (Fetal) Diagnostic Testing File Name: Origination: Last CAP Review: Next CAP Review: Last Review: invasive_prenatal_(fetal)_diagnostic_testing 12/2014 3/2018
More informationCHROMOSOME MICROARRAY TESTING
CHROMOSOME MICROARRAY TESTING UnitedHealthcare Commercial Medical Policy Policy Number: 2017T0559J Effective Date: August 1, 2017 Table of Contents Page INSTRUCTIONS FOR USE... 1 BENEFIT CONSIDERATIONS...
More informationMedical Policy. MP Invasive Prenatal (Fetal) Diagnostic Testing
Medical Policy MP 2.04.116 BCBSA Ref. Policy: 2.04.116 Last Review: 04/30/2018 Effective Date: 04/30/2018 Section: Medicine Related Policies 2.04.59 Genetic Testing for Developmental Delay/Intellectual
More informationCHROMOSOME MICROARRAY TESTING (NON-ONCOLOGY CONDITIONS)
CHROMOSOME MICROARRAY TESTING (NON-ONCOLOGY CONDITIONS) UnitedHealthcare Oxford Clinical Policy Policy Number: LABORATORY 016.12 T2 Effective Date: June 1, 2018 Table of Contents Page INSTRUCTIONS FOR
More informationMultiplex target enrichment using DNA indexing for ultra-high throughput variant detection
Multiplex target enrichment using DNA indexing for ultra-high throughput variant detection Dr Elaine Kenny Neuropsychiatric Genetics Research Group Institute of Molecular Medicine Trinity College Dublin
More informationNature Biotechnology: doi: /nbt.1904
Supplementary Information Comparison between assembly-based SV calls and array CGH results Genome-wide array assessment of copy number changes, such as array comparative genomic hybridization (acgh), is
More informationUnderstanding the Human Karyotype Colleen Jackson Cook, Ph.D.
Understanding the Human Karyotype Colleen Jackson Cook, Ph.D. SUPPLEMENTAL READING Nussbaum, RL, McInnes, RR, and Willard HF (2007) Thompson and Thompson Genetics in Medicine, 7th edition. Saunders: Philadelphia.
More informationDetermination of Genomic Imbalances by Genome-wide Screening Approaches
Overview Determination of Genomic Imbalances by Genome-wide Screening Approaches Károly Szuhai Introduction/Methodologies Applications/Results Conclusion Approaches Introduction/Methodologies Chromosome
More informationGlobal variation in copy number in the human genome
Global variation in copy number in the human genome Redon et. al. Nature 444:444-454 (2006) 12.03.2007 Tarmo Puurand Study 270 individuals (HapMap collection) Affymetrix 500K Whole Genome TilePath (WGTP)
More informationUsing the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep
Using the Bravo Liquid-Handling System for Next Generation Sequencing Sample Prep Tom Walsh, PhD Division of Medical Genetics University of Washington Next generation sequencing Sanger sequencing gold
More informationApproach to Mental Retardation and Developmental Delay. SR Ghaffari MSc MD PhD
Approach to Mental Retardation and Developmental Delay SR Ghaffari MSc MD PhD Introduction Objectives Definition of MR and DD Classification Epidemiology (prevalence, recurrence risk, ) Etiology Importance
More informationInvasive Prenatal (Fetal) Diagnostic Testing
Protocol Invasive Prenatal (Fetal) Diagnostic Testing (204116) Medical Benefit Effective Date: 04/01/18 Next Review Date: 01/19 Preauthorization Yes Review Dates: 01/15, 01/16, 01/17, 01/18 Preauthorization
More informationPG-Seq NGS Kit for Preimplantation Genetic Screening
Application Note: PG-Seq Validation Study PG-Seq NGS Kit for Preimplantation Genetic Screening Validation using Multi (5-10) Cells and Single Cells from euploid and aneuploid cell lines Introduction Advances
More informationUnderstanding DNA Copy Number Data
Understanding DNA Copy Number Data Adam B. Olshen Department of Epidemiology and Biostatistics Helen Diller Family Comprehensive Cancer Center University of California, San Francisco http://cc.ucsf.edu/people/olshena_adam.php
More informationAgilent s Copy Number Variation (CNV) Portfolio
Technical Overview Agilent s Copy Number Variation (CNV) Portfolio Abstract Copy Number Variation (CNV) is now recognized as a prevalent form of structural variation in the genome contributing to human
More informationMost severely affected will be the probe for exon 15. Please keep an eye on the D-fragments (especially the 96 nt fragment).
SALSA MLPA probemix P343-C3 Autism-1 Lot C3-1016. As compared to version C2 (lot C2-0312) five reference probes have been replaced, one reference probe added and several lengths have been adjusted. Warning:
More informationSNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: LOSS,
More information%(6/31) [DOI] /j.issn
750 2016 9 1 41 9 [ ] 2012 2 2015 5 31 20~37 21~27 31 G 4 1 26 23 3 11.54%(3/26) 4 / 21 6 19.35%(6/31) [ ] [ ] R714.53 [ ] A [ ] 0577-7402(2016)09-0750-08 [DOI] 10.11855/j.issn.0577-7402.2016.09.10 Application
More informationSNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY.
SAMPLE REPORT SNP Array NOTE: THIS IS A SAMPLE REPORT AND MAY NOT REFLECT ACTUAL PATIENT DATA. FORMAT AND/OR CONTENT MAY BE UPDATED PERIODICALLY. RESULTS SNP Array Copy Number Variations Result: GAIN,
More informationreview Genetics IN Medicine 13
January 2008 Vol. 10 No. 1 review Pre- and postnatal genetic testing by array-comparative genomic hybridization: genetic counseling perspectives Sandra Darilek, MS, Patricia Ward, MS, Amber Pursley, MS,
More informationStructural Variation and Medical Genomics
Structural Variation and Medical Genomics Andrew King Department of Biomedical Informatics July 8, 2014 You already know about small scale genetic mutations Single nucleotide polymorphism (SNPs) Deletions,
More informationAVENIO ctdna Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB
Analysis Kits The complete NGS liquid biopsy solution EMPOWER YOUR LAB Analysis Kits Next-generation performance in liquid biopsies 2 Accelerating clinical research From liquid biopsy to next-generation
More informationComprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks?
Comprehensive Chromosome Screening Is NextGen Likely to be the Final Best Platform and What are its Advantages and Quirks? Embryo 1 Embryo 2 combine samples for a single sequencing chip Barcode 1 CTAAGGTAAC
More informationSALSA MLPA probemix P169-C2 HIRSCHSPRUNG-1 Lot C As compared to version C1 (lot C1-0612), the length of one probe has been adjusted.
mix P169-C2 HIRSCHSPRUNG-1 Lot C2-0915. As compared to version C1 (lot C1-0612), the length of one has been adjusted. Hirschsprung disease (HSCR), or aganglionic megacolon, is a congenital disorder characterised
More informationNext Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters
Next Generation Sequencing as a tool for breakpoint analysis in rearrangements of the globin-gene clusters XXXth International Symposium on Technical Innovations in Laboratory Hematology Honolulu, Hawaii
More informationCYTOGENETICS Dr. Mary Ann Perle
CYTOGENETICS Dr. Mary Ann Perle I) Mitosis and metaphase chromosomes A) Chromosomes are most fully condensed and clearly distinguishable during mitosis. B) Mitosis (M phase) takes 1 to 2 hrs and is divided
More informationAndrew Parrish, Richard Caswell, Garan Jones, Christopher M. Watson, Laura A. Crinnion 3,4, Sian Ellard 1,2
METHOD ARTICLE An enhanced method for targeted next generation sequencing copy number variant detection using ExomeDepth [version 1; referees: 1 approved, 1 approved with reservations] 1 2 1 3,4 Andrew
More informationStatistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies
Statistical Analysis of Single Nucleotide Polymorphism Microarrays in Cancer Studies Stanford Biostatistics Workshop Pierre Neuvial with Henrik Bengtsson and Terry Speed Department of Statistics, UC Berkeley
More informationCopy number imbalances detected with a BAC-based array comparative genomic hybridization platform in congenital diaphragmatic hernia fetuses
Copy number imbalances detected with a BAC-based array comparative genomic hybridization platform in congenital diaphragmatic hernia fetuses I.N. Machado 1,2, J.K. Heinrich 2, R. Barini 1 and C.F.A. Peralta
More informationCanadian College of Medical Geneticists (CCMG) Cytogenetics Examination. May 4, 2010
Canadian College of Medical Geneticists (CCMG) Cytogenetics Examination May 4, 2010 Examination Length = 3 hours Total Marks = 100 (7 questions) Total Pages = 8 (including cover sheet and 2 pages of prints)
More informationCurrent controversies in prenatal diagnosis 3: is conventional chromosome analysis necessary in the post-array CGH era?
PRENATAL DIAGNOSIS Prenat Diagn 2011; 31: 235 243. Published online 10 February 2011 in Wiley Online Library (wileyonlinelibrary.com).2722 DEBATE Current controversies in prenatal diagnosis 3: is conventional
More informationThe Importance of Coverage Uniformity Over On-Target Rate for Efficient Targeted NGS
WHITE PAPER The Importance of Coverage Uniformity Over On-Target Rate for Efficient Targeted NGS Yehudit Hasin-Brumshtein, Ph.D., Maria Celeste M. Ramirez, Ph.D., Leonardo Arbiza, Ph.D., Ramsey Zeitoun,
More informationFaravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University
Faravareh Khordadpoor (PhD in molecular genetics) 1- Tehran Medical Genetics Laboratory 2- Science and research branch, Islamic Azad University 1395 21 مشاوره ژنتیک و نقش آن در پیش گیری از معلولیت ها 20
More informationMutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research
Mutation Detection and CNV Analysis for Illumina Sequencing data from HaloPlex Target Enrichment Panels using NextGENe Software for Clinical Research Application Note Authors John McGuigan, Megan Manion,
More informationAnalysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers
Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Gordon Blackshields Senior Bioinformatician Source BioScience 1 To Cancer Genetics Studies
More informationGenetic Testing for Single-Gene and Multifactorial Conditions
Clinical Appropriateness Guidelines Genetic Testing for Single-Gene and Multifactorial Conditions EFFECTIVE DECEMBER 1, 2017 Appropriate.Safe.Affordable 2017 AIM Specialty Health 2069-1217 Table of Contents
More informationRole of FISH in Hematological Cancers
Role of FISH in Hematological Cancers Thomas S.K. Wan PhD,FRCPath,FFSc(RCPA) Honorary Professor, Department of Pathology & Clinical Biochemistry, Queen Mary Hospital, University of Hong Kong. e-mail: wantsk@hku.hk
More informationPractical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs
Practical challenges that copy number variation and whole genome sequencing create for genetic diagnostic labs Joris Vermeesch, Center for Human Genetics K.U.Leuven, Belgium ESHG June 11, 2010 When and
More informationPerformance Characteristics BRCA MASTR Plus Dx
Performance Characteristics BRCA MASTR Plus Dx with drmid Dx for Illumina NGS systems Manufacturer Multiplicom N.V. Galileïlaan 18 2845 Niel Belgium Table of Contents 1. Workflow... 4 2. Performance Characteristics
More informationMRC-Holland MLPA. Description version 08; 30 March 2015
SALSA MLPA probemix P351-C1 / P352-D1 PKD1-PKD2 P351-C1 lot C1-0914: as compared to the previous version B2 lot B2-0511 one target probe has been removed and three reference probes have been replaced.
More informationChIP-seq data analysis
ChIP-seq data analysis Harri Lähdesmäki Department of Computer Science Aalto University November 24, 2017 Contents Background ChIP-seq protocol ChIP-seq data analysis Transcriptional regulation Transcriptional
More informationMolecular Markers. Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC
Molecular Markers Marcie Riches, MD, MS Associate Professor University of North Carolina Scientific Director, Infection and Immune Reconstitution WC Overview Testing methods Rationale for molecular testing
More informationTargeted qpcr. Debate on PGS Technology: Targeted vs. Whole genome approach. Discolsure Stake shareholder of GENETYX S.R.L
Antonio Capalbo, PhD Laboratory Director GENETYX, reproductive genetics laboratory, Italy PGT responsible GENERA centers for reproductive medicine, Italy Debate on PGS Technology: Targeted vs. Whole genome
More informationMRC-Holland MLPA. Description version 29;
SALSA MLPA KIT P003-B1 MLH1/MSH2 Lot 1209, 0109. As compared to the previous lots 0307 and 1006, one MLH1 probe (exon 19) and four MSH2 probes have been replaced. In addition, one extra MSH2 exon 1 probe,
More informationSALSA MLPA KIT P050-B2 CAH
SALSA MLPA KIT P050-B2 CAH Lot 0510, 0909, 0408: Compared to lot 0107, extra control fragments have been added at 88, 96, 100 and 105 nt. The 274 nt probe gives a higher signal in lot 0510 compared to
More informationAssociating Copy Number and SNP Variation with Human Disease. Autism Segmental duplication Neurobehavioral, includes social disability
Technical Note Associating Copy Number and SNP Variation with Human Disease Abstract The Genome-Wide Human SNP Array 6.0 is an affordable tool to examine the role of copy number variation in disease by
More informationCost effective, computer-aided analytical performance evaluation of chromosomal microarrays for clinical laboratories
University of Iowa Iowa Research Online Theses and Dissertations Summer 2012 Cost effective, computer-aided analytical performance evaluation of chromosomal microarrays for clinical laboratories Corey
More informationBenefits and pitfalls of new genetic tests
Benefits and pitfalls of new genetic tests Amanda Krause Division of Human Genetics, NHLS and University of the Witwatersrand Definition of Genetic Testing the analysis of human DNA, RNA, chromosomes,
More informationSharan Goobie, MD, MSc, FRCPC
Sharan Goobie, MD, MSc, FRCPC Chromosome testing in 2014 Presenter Disclosure: Sharan Goobie has no potential for conflict of interest with this presentation Objectives Review of standard genetic investigations
More informationMEDICAL GENOMICS LABORATORY. Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG)
Next-Gen Sequencing and Deletion/Duplication Analysis of NF1 Only (NF1-NG) Ordering Information Acceptable specimen types: Fresh blood sample (3-6 ml EDTA; no time limitations associated with receipt)
More informationNo mutations were identified.
Hereditary High Cholesterol Test ORDERING PHYSICIAN PRIMARY CONTACT SPECIMEN Report date: Aug 1, 2017 Dr. Jenny Jones Sample Medical Group 123 Main St. Sample, CA Kelly Peters Sample Medical Group 123
More informationAdvance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library
Advance Your Genomic Research Using Targeted Resequencing with SeqCap EZ Library Marilou Wijdicks International Product Manager Research For Life Science Research Only. Not for Use in Diagnostic Procedures.
More informationMRC-Holland MLPA. Description version 29; 31 July 2015
SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0114. As compared to the previous B2 version (lot 0813 and 0912), 11 target probes are replaced or added, and 10 new reference probes are included. P082
More informationPROVIDER POLICIES & PROCEDURES
PROVIDER POLICIES & PROCEDURES COMPARATIVE GENOMIC HYBRIDIZATION (CGH) MICROARRAY TESTING FOR DEVELOPMENTAL DELAY, AUTISM SPECTRUM DISORDER AND INTELLECTUAL DISABILITY The purpose of this policy is to
More informationChromothripsis: A New Mechanism For Tumorigenesis? i Fellow s Conference Cheryl Carlson 6/10/2011
Chromothripsis: A New Mechanism For Tumorigenesis? i Fellow s Conference Cheryl Carlson 6/10/2011 Massive Genomic Rearrangement Acquired in a Single Catastrophic Event during Cancer Development Cell 144,
More informationSALSA MLPA probemix P315-B1 EGFR
SALSA MLPA probemix P315-B1 EGFR Lot B1-0215 and B1-0112. As compared to the previous A1 version (lot 0208), two mutation-specific probes for the EGFR mutations L858R and T709M as well as one additional
More informationAn Overview of Cytogenetics. Bridget Herschap, M.D. 9/23/2013
An Overview of Cytogenetics Bridget Herschap, M.D. 9/23/2013 Objectives } History and Introduction of Cytogenetics } Overview of Current Techniques } Common cytogenetic tests and their clinical application
More informationSALSA MLPA KIT P060-B2 SMA
SALSA MLPA KIT P6-B2 SMA Lot 111, 511: As compared to the previous version B1 (lot 11), the 88 and 96 nt DNA Denaturation control fragments have been replaced (QDX2). Please note that, in contrast to the
More informationClinical evaluation of microarray data
Clinical evaluation of microarray data David Amor 19 th June 2011 Single base change Microarrays 3-4Mb What is a microarray? Up to 10 6 bits of Information!! Highly multiplexed FISH hybridisations. Microarray
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Greco E, Minasi MG, Fiorentino F. Healthy babies after intrauterine
More informationApplication of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation
Pediatr Neonatol 2008;49(6):213 217 REVIEW ARTICLE Application of Array-based Comparative Genome Hybridization in Children with Developmental Delay or Mental Retardation Jao-Shwann Liang 1,2 *, Keiko Shimojima
More informationMRC-Holland MLPA. Description version 18; 09 September 2015
SALSA MLPA probemix P090-A4 BRCA2 Lot A4-0715, A4-0714, A4-0314, A4-0813, A4-0712: Compared to lot A3-0710, the 88 and 96 nt control fragments have been replaced (QDX2). This product is identical to the
More informationTHE PENNSYLVANIA STATE UNIVERSITY SCHREYER HONORS COLLEGE DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
THE PENNSYLVANIA STATE UNIVERSITY SCHREYER HONORS COLLEGE DEPARTMENT OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GENOME-WIDE MICROARRAY ANALYSIS IN A CASE-CONTROL STUDY REVEALS EVELATED LEVEL OF GLOBAL COPY
More informationUpdating penetrance estimates for syndromes with variable phenotypic manifestation. Adele Corrigan June 27th
Updating penetrance estimates for syndromes with variable phenotypic manifestation Adele Corrigan June 27th Background Array CGH has led to increased identification of copy number variants (CNVs) Our understanding
More informationIntroduction to genetic variation. He Zhang Bioinformatics Core Facility 6/22/2016
Introduction to genetic variation He Zhang Bioinformatics Core Facility 6/22/2016 Outline Basic concepts of genetic variation Genetic variation in human populations Variation and genetic disorders Databases
More informationNational Medical Policy
National Medical Policy Subject: Policy Number: Single Nucleotide Polymorphism (SNP) Chromosomal Microarray Analysis for Prenatal Testing and Intellectual Disability, Developmental Delay, and Multiple
More informationMRC-Holland MLPA. Description version 07; 26 November 2015
SALSA MLPA probemix P266-B1 CLCNKB Lot B1-0415, B1-0911. As compared to version A1 (lot A1-0908), one target probe for CLCNKB (exon 11) has been replaced. In addition, one reference probe has been replaced
More informationMPS for translocations
MPS for translocations Filip Van Nieuwerburgh, Ph.D. Lab of Pharmaceutical Biotechnology NXTGNT massively parallel sequencing facility, Ghent University In collaboration with: Center for Medical Genetics,
More informationThe role of cytogenomics in the diagnostic work-up of Chronic Lymphocytic Leukaemia
The role of cytogenomics in the diagnostic work-up of Chronic Lymphocytic Leukaemia Adrian Zordan, Meaghan Wall, Ruth MacKinnon, Pina D Achille & Lynda Campbell Victorian Cancer Cytogenetics Service (VCCS)
More informationMultiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016
Multiple Copy Number Variations in a Patient with Developmental Delay ASCLS- March 31, 2016 Marwan Tayeh, PhD, FACMG Director, MMGL Molecular Genetics Assistant Professor of Pediatrics Department of Pediatrics
More informationWhat s the Human Genome Project Got to Do with Developmental Disabilities?
What s the Human Genome Project Got to Do with Developmental Disabilities? Disclosures Neither speaker has anything to disclose. Phase Two: Interpretation Officially started in October 1990 Goals of the
More informationDiagnosis of parental balanced reciprocal translocations by trophectoderm biopsy and comprehensive chromosomal screening
Diagnosis of parental balanced reciprocal translocations by trophectoderm biopsy and comprehensive chromosomal screening Lian Liu, MD Co-Authors: L. W. Sundheimer1, L. Liu2, R. P. Buyalos1,3, G. Hubert1,3,
More information24-Feb-15. Learning objectives. Family genetics: The future??? The traditional genetics. Genetics and reproduction in early 2015.
Learning objectives Family genetics: The future??? Peter Illingworth Medical Director IVFAustralia Understand how genetic problems may affect successful conception Consider the possible conditions and
More informationGenomic complexity and arrays in CLL. Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy
Genomic complexity and arrays in CLL Gian Matteo Rigolin, MD, PhD St. Anna University Hospital Ferrara, Italy Clinical relevance of genomic complexity (GC) in CLL GC has been identified as a critical negative
More informationSEAMLESS CGH DIAGNOSTIC TESTING
SEAMLESS CGH DIAGNOSTIC TESTING GENETISURE DX POSTNATAL ASSAY Informed decisions start with a complete microarray platform for postnatal analysis For In Vitro Diagnostic Use INTENDED USE: GenetiSure Dx
More informationKaryology. Preparation and study of karyotypes is part of Cytogenetics.
Chromosomal Karyotyping Karyology Karyotyping - process of pairing and ordering all chromosomes of an organism, thus providing a genome-wide snapshot of an individual's chromosomes. Karyotypes describe
More informationMRC-Holland MLPA. Description version 30; 06 June 2017
SALSA MLPA probemix P081-C1/P082-C1 NF1 P081 Lot C1-0517, C1-0114. As compared to the previous B2 version (lot B2-0813, B2-0912), 11 target probes are replaced or added, and 10 new reference probes are
More informationClinical Interpretation of Cancer Genomes
IGENZ Ltd, Auckland, New Zealand Clinical Interpretation of Cancer Genomes Dr Amanda Dixon-McIver www.igenz.co.nz 1992 Slovenia and Croatia gain independence USA and Russia declare the Cold War over Steffi
More informationNew Molecular Techniques for the Prenatal Detection of Chromosomal Aneuploidy
SOGC TECHNICAL UPDATE No. 210, July 2008 New Molecular Techniques for the Prenatal Detection of Chromosomal Aneuploidy This technical update has been prepared by the Genetics Committee and approved by
More informationMRC-Holland MLPA. Description version 06; 23 December 2016
SALSA MLPA probemix P417-B2 BAP1 Lot B2-1216. As compared to version B1 (lot B1-0215), two reference probes have been added and two target probes have a minor change in length. The BAP1 (BRCA1 associated
More informationcn.mops - Mixture of Poissons for CNV detection in NGS data Günter Klambauer Institute of Bioinformatics, Johannes Kepler University Linz
Software Manual Institute of Bioinformatics, Johannes Kepler University Linz cn.mops - Mixture of Poissons for CNV detection in NGS data Günter Klambauer Institute of Bioinformatics, Johannes Kepler University
More informationDETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING. John Archer. Faculty of Life Sciences University of Manchester
DETECTION OF LOW FREQUENCY CXCR4-USING HIV-1 WITH ULTRA-DEEP PYROSEQUENCING John Archer Faculty of Life Sciences University of Manchester HIV Dynamics and Evolution, 2008, Santa Fe, New Mexico. Overview
More information